☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Chronic Pain
Alvotech Seeks to End the AbbVie's Wrong Monopoly on Humira and Develops New Biosimilar for Chronic Pain
May 11, 2021
Lilly Signs a License Agreement with Asahi Kasei Pharma for AK1780 to Treat Chronic Pain
January 29, 2021
Abbott Launches IonicRF Generator for Patients with Chronic Pain in the US
November 11, 2020
Pfizer and Eli Lilly Report the US FDA Acceptance of BLA for Tanezumab to Treat Chronic Pain Due to Moderate-to-Severe Osteoarthri...
March 2, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.